NCT03653546 2025-09-10
BM
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 2/3 Completed
Clinical Trials
6 trialsNCT02326285 2018-01-23
NeoIntercal
AIO-Studien-gGmbH
Phase 2/3 Terminated
NCT00259064 2016-06-02
INSTEP
AstraZeneca
Phase 2/3 Completed
NCT02387086 2015-03-12
Gefitinib Combined With Thalidomide to Treat NSCLC
Shaanxi Provincial People's Hospital
Phase 2/3 Unknown
NCT02338011 2015-01-26
EGFR
Shanghai Chest Hospital
Phase 2/3 Unknown
NCT00234429 2007-12-18
A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma
AstraZeneca
Phase 2/3 Completed